CA2128783A1 - Injectable ceramic compositions and methods for their preparation and use - Google Patents

Injectable ceramic compositions and methods for their preparation and use

Info

Publication number
CA2128783A1
CA2128783A1 CA002128783A CA2128783A CA2128783A1 CA 2128783 A1 CA2128783 A1 CA 2128783A1 CA 002128783 A CA002128783 A CA 002128783A CA 2128783 A CA2128783 A CA 2128783A CA 2128783 A1 CA2128783 A1 CA 2128783A1
Authority
CA
Canada
Prior art keywords
compositions
collagen
ceramic matrix
preparation
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002128783A
Other languages
French (fr)
Other versions
CA2128783C (en
Inventor
Donald G. Wallace
Hugh Mcmullin
George Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biomaterials Corp
Original Assignee
Donald G. Wallace
Hugh Mcmullin
George Chu
Collagen Corporation
Cohesion Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donald G. Wallace, Hugh Mcmullin, George Chu, Collagen Corporation, Cohesion Technologies, Inc. filed Critical Donald G. Wallace
Publication of CA2128783A1 publication Critical patent/CA2128783A1/en
Application granted granted Critical
Publication of CA2128783C publication Critical patent/CA2128783C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00179—Ceramics or ceramic-like structures
    • A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite

Abstract

Injectable implant compositions comprise a biocompatible ceramic matrix present in a fluid carrier, where the ceramic matrix comprises particles having a size distribution in the range from 50 µm to 250 µm. Optionally, the compositions, may further comprise collagen, where the relative amounts of collagen and ceramic matrix at least partly determine the physical properties of implants formed by injecting the compositions. The fluid carrier is an aqueous buffered medium, typically including an organic polymer base material when there is no collagen present in the composition.
The compositions are particularly suitable for repair and augmentation of soft and hard tissues by injection.
CA002128783A 1992-02-28 1993-02-16 Injectable ceramic compositions and methods for their preparation and use Expired - Lifetime CA2128783C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84364692A 1992-02-28 1992-02-28
US07/843,646 1992-02-28
PCT/US1993/001378 WO1993016657A1 (en) 1992-02-28 1993-02-16 Injectable ceramic compositions and methods for their preparation and use

Publications (2)

Publication Number Publication Date
CA2128783A1 true CA2128783A1 (en) 1993-09-02
CA2128783C CA2128783C (en) 2004-10-12

Family

ID=25290604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002128783A Expired - Lifetime CA2128783C (en) 1992-02-28 1993-02-16 Injectable ceramic compositions and methods for their preparation and use

Country Status (9)

Country Link
US (1) US5352715A (en)
EP (2) EP0627899B1 (en)
JP (1) JPH07504106A (en)
AT (2) ATE269371T1 (en)
AU (1) AU666712B2 (en)
CA (1) CA2128783C (en)
DE (2) DE69333556T2 (en)
ES (1) ES2167330T3 (en)
WO (1) WO1993016657A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389017B1 (en) 1999-07-08 2013-03-05 Cap Biotechnology, Inc. Calcium-containing structures and methods of making and using the same

Families Citing this family (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5219895A (en) * 1991-01-29 1993-06-15 Autogenesis Technologies, Inc. Collagen-based adhesives and sealants and methods of preparation and use thereof
AU674500B2 (en) 1991-11-04 1997-01-02 Genetics Institute, Llc Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
ATE319823T1 (en) 1993-12-07 2006-03-15 Inst Genetics Llc BMP-12, BMP-13 AND TENDON-INDUCING COMPOSITIONS CONTAINING SAME
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US7150879B1 (en) 1995-05-19 2006-12-19 Etex Corporation Neutral self-setting calcium phosphate paste
US6117456A (en) * 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6541037B1 (en) 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
AU3069997A (en) * 1996-05-01 1997-11-19 Us Biomaterials Corporation Bioactive ceramics and method of preparing bioactive ceramics
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US6051247A (en) * 1996-05-30 2000-04-18 University Of Florida Research Foundation, Inc. Moldable bioactive compositions
US5792478A (en) * 1996-07-08 1998-08-11 Advanced Uro Science Tissue injectable composition and method of use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6756060B1 (en) 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US5834008A (en) * 1996-09-19 1998-11-10 U.S. Biomaterials Corp. Composition and method for acceleration of wound and burn healing
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
AU734691B2 (en) 1996-10-16 2001-06-21 Life Science Enterprises, Inc. Bioceramic compositions
US7517539B1 (en) 1996-10-16 2009-04-14 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
US6417247B1 (en) * 1997-10-14 2002-07-09 Beth L. Armstrong Polymer/ceramic composites
US6423343B1 (en) 1998-01-23 2002-07-23 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US6224629B1 (en) * 1998-12-09 2001-05-01 Purzer Pharmaceuticals Co. Ltd. Bone substitute composition and process of preparation thereof
US6383519B1 (en) * 1999-01-26 2002-05-07 Vita Special Purpose Corporation Inorganic shaped bodies and methods for their production and use
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
PT1150918E (en) 1999-02-03 2005-01-31 Biosante Pharmaceuticals Inc METHOD OF MANUFACTURE OF CALCIUM PHOSPHATE THERAPEUTIC PARTICLES
WO2000045870A1 (en) * 1999-02-04 2000-08-10 Sdgi Holdings, Inc. Osteogenic paste compositions and uses thereof
EP1185247A4 (en) 1999-04-29 2008-09-17 Usbiomaterials Corp Anti-inflammatory bioactive glass particulates
DK1196150T3 (en) 1999-06-14 2005-11-21 Imp College Innovations Ltd Solvent-containing sol-gel-derived bioglass compositions
US6458162B1 (en) 1999-08-13 2002-10-01 Vita Special Purpose Corporation Composite shaped bodies and methods for their production and use
US6183498B1 (en) 1999-09-20 2001-02-06 Devore Dale P. Methods and products for sealing a fluid leak in a tissue
EP1475109A1 (en) * 1999-10-15 2004-11-10 Genetics Institute, LLC Formulations for delivery of osteogenic proteins
DK1223990T3 (en) * 1999-10-15 2004-11-29 Inst Genetics Llc Formulations of hyaluronic acid for delivery of osteogenic proteins
PT1220693E (en) * 1999-10-15 2005-02-28 Inst Genetics Llc FORMULATIONS FOR OSTEOGENIC PROTEIN LIBERATION
US7004977B2 (en) 1999-11-24 2006-02-28 A Enterprises, Inc. Soft tissue substitute and method of soft tissue reformation
US6521244B1 (en) * 2000-06-13 2003-02-18 Nozomu Kanesaka Body filling material
DE10032220A1 (en) 2000-07-03 2002-01-24 Sanatis Gmbh Magnesium ammonium phosphate cements, their manufacture and use
DE10054857B4 (en) * 2000-11-06 2005-02-17 Bohmann, Anton, Dr.med., Dipl.-Ing. (FH) System for the production of individually shapable bone replacement
WO2002040071A1 (en) * 2000-11-14 2002-05-23 Osteogenesis Co., Ltd. Compositions for forming bone or periodontium and injections for forming bone or periodontium
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20020193883A1 (en) * 2001-01-25 2002-12-19 Wironen John F. Injectable porous bone graft materials
US6685626B2 (en) 2001-02-02 2004-02-03 Regeneration Technologies, Inc. Compositions, devices, methods, and kits for induction of adhesions
US20020176893A1 (en) * 2001-02-02 2002-11-28 Wironen John F. Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue
ES2305246T3 (en) 2001-06-01 2008-11-01 Wyeth COMPOSITIONS FOR THE SYSTEMIC ADMINISTRATION OF SEQUENCES CODING OSEAS MORPHOGENETIC PROTEINS.
TWI267378B (en) * 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US7105182B2 (en) * 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
US20030026770A1 (en) * 2001-07-25 2003-02-06 Szymaitis Dennis W. Periodontal regeneration composition and method of using same
TW200638946A (en) * 2002-05-17 2006-11-16 Wyeth Corp Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
US7273523B2 (en) 2002-06-07 2007-09-25 Kyphon Inc. Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
EP1525011B1 (en) * 2002-07-31 2016-08-17 DENTSPLY International Inc. Bone repair putty comprising porous particulate and carrier gel
JPWO2004105825A1 (en) * 2003-01-10 2006-07-20 多木化学株式会社 Biomaterial for bone formation, formulation for injection containing the material, kit for preparing the material, and bone formation method using them
FR2850282B1 (en) * 2003-01-27 2007-04-06 Jerome Asius INJECTABLE IMPLANT BASED ON CERAMIC FOR THE FILLING OF WRINKLES, CUTANEOUS DEPRESSIONS AND SCARS, AND ITS PREPARATION
CA2521623C (en) * 2003-04-11 2015-03-17 Etex Corporation Osteoinductive bone material
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
CN1878565B (en) 2003-09-12 2011-01-12 惠氏公司 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
US8012210B2 (en) 2004-01-16 2011-09-06 Warsaw Orthopedic, Inc. Implant frames for use with settable materials and related methods of use
US7189263B2 (en) 2004-02-03 2007-03-13 Vita Special Purpose Corporation Biocompatible bone graft material
US20070190101A1 (en) * 2004-03-31 2007-08-16 Chunlin Yang Flowable bone grafts
EP1742648A4 (en) * 2004-04-15 2009-03-04 Etex Corp Delayed-setting calcium phosphate pastes
MXPA06012420A (en) 2004-04-27 2007-03-28 Kyphon Inc Bone substitute compositions and method of use.
US9220595B2 (en) 2004-06-23 2015-12-29 Orthovita, Inc. Shapeable bone graft substitute and instruments for delivery thereof
WO2006026731A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
WO2006026554A1 (en) * 2004-08-30 2006-03-09 Neville Alleyne Method of using an implant for treatment of ligaments and tendons
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
BRPI0518383A2 (en) 2004-10-25 2008-11-18 Polyzenix Gmbh Chargeable polymeric particles for therapeutical and / or diagnostic applications and methods for preparing and using them
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20090041812A1 (en) 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use
DE102005034420A1 (en) * 2004-12-23 2006-07-06 Ossacur Ag Gel-like material for filling bone and / or cartilage defects
EP1863518A2 (en) * 2005-03-30 2007-12-12 Wyeth Methods for stimulating hair growth by administering bmps
US7416602B2 (en) 2005-04-08 2008-08-26 Howmedica Leibinger, Inc. Calcium phosphate cement
US7459018B2 (en) 2005-04-08 2008-12-02 Howmedica Leibinger Inc. Injectable calcium phosphate cement
WO2006122183A2 (en) * 2005-05-10 2006-11-16 Cytophil, Inc. Injectable hydrogels and methods of making and using same
US7651701B2 (en) * 2005-08-29 2010-01-26 Sanatis Gmbh Bone cement composition and method of making the same
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
EP1976460A4 (en) 2006-01-19 2012-06-20 Warsaw Orthopedic Inc Injectable and moldable bone substitute materials
CA2637606C (en) 2006-01-19 2013-03-19 Osteotech, Inc. Porous osteoimplant
US20070184087A1 (en) * 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
DE102006011211A1 (en) * 2006-03-02 2007-09-06 Ossacur Ag Material for the treatment of bone and / or cartilage defects
US7754005B2 (en) * 2006-05-02 2010-07-13 Kyphon Sarl Bone cement compositions comprising an indicator agent and related methods thereof
CN101454030B (en) 2006-05-31 2013-06-26 巴克斯特国际公司 Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
US7507286B2 (en) * 2006-06-08 2009-03-24 Sanatis Gmbh Self-foaming cement for void filling and/or delivery systems
EP2040765A2 (en) 2006-06-29 2009-04-01 Orthovita, INC. Bioactive bone graft substitute
TWI436793B (en) 2006-08-02 2014-05-11 Baxter Int Rapidly acting dry sealant and methods for use and manufacture
DE102006042142A1 (en) 2006-09-06 2008-03-27 Curasan Ag Phase- and sedimentation-stable, plastically deformable preparation with intrinsic pore formation, for example for filling bone defects or for use as a bone substitute material, and method for their preparation
WO2008039382A2 (en) * 2006-09-21 2008-04-03 Kyphon Sarl Diammonium phosphate and other ammonium salts and their use in preventing clotting
EP2068952A2 (en) * 2006-10-05 2009-06-17 CAM Aesthetics B.V. i.o. Hydroxyapatite tissue filler and its preparation and use
WO2008051864A2 (en) * 2006-10-24 2008-05-02 Neville Alleyne Method of treating spinal internal disk derangement
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US20080299172A1 (en) * 2007-06-04 2008-12-04 Stuart Young Tissue repair implant
FR2918658B1 (en) * 2007-07-09 2010-12-03 Centre Nat Rech Scient BIOACTIVE LENSES DOPED IN STRONTIUM.
JP2011500237A (en) 2007-10-30 2011-01-06 バクスター・インターナショナル・インコーポレイテッド Use of regenerative biofunctional collagen biomatrix to treat visceral or cavity wall defects
US20090131867A1 (en) 2007-11-16 2009-05-21 Liu Y King Steerable vertebroplasty system with cavity creation element
US20090131886A1 (en) 2007-11-16 2009-05-21 Liu Y King Steerable vertebroplasty system
US9510885B2 (en) 2007-11-16 2016-12-06 Osseon Llc Steerable and curvable cavity creation system
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
US20100004700A1 (en) * 2008-03-05 2010-01-07 Neville Alleyne Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US7968616B2 (en) * 2008-04-22 2011-06-28 Kyphon Sarl Bone cement composition and method
US20100016808A1 (en) * 2008-07-17 2010-01-21 Bioform Medical, Inc. Thin-Walled Delivery System
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US20100298832A1 (en) 2009-05-20 2010-11-25 Osseon Therapeutics, Inc. Steerable curvable vertebroplasty drill
PT2442835E (en) 2009-06-16 2015-03-23 Baxter Healthcare Sa Hemostatic sponge
JP2013514093A (en) 2009-12-16 2013-04-25 バクスター・インターナショナル・インコーポレイテッド Hemostatic sponge
SA111320355B1 (en) 2010-04-07 2015-01-08 Baxter Heathcare S A Hemostatic sponge
WO2011137377A1 (en) 2010-04-29 2011-11-03 Dfine, Inc. System for use in treatment of vertebral fractures
JP6289096B2 (en) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Process for making a dry and stable hemostatic composition
US9084728B2 (en) 2010-06-01 2015-07-21 Baxter International Inc. Process for making dry and stable hemostatic compositions
CN103037845B (en) 2010-06-01 2015-11-25 巴克斯特国际公司 For the preparation of the method for dry, stable hemostatic composition
ES2714701T3 (en) 2010-11-10 2019-05-29 Stryker European Holdings I Llc Process for the preparation of a polymeric bone foam
CA2817584C (en) 2010-11-15 2018-01-02 Zimmer Orthobiologics, Inc. Bone void fillers
US9447169B2 (en) 2011-03-04 2016-09-20 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
US9265830B2 (en) 2011-04-20 2016-02-23 Warsaw Orthopedic, Inc. Implantable compositions and methods for preparing the same
US20130090291A1 (en) 2011-10-11 2013-04-11 Baxter Healthcare S.A. Hemostatic compositions
AU2012318257B2 (en) 2011-10-11 2015-10-01 Baxter Healthcare S.A. Hemostatic compositions
US20130108671A1 (en) 2011-10-27 2013-05-02 Baxter Healthcare S.A. Hemostatic compositions
JP6241624B2 (en) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス Pressurized container containing hemostatic paste
KR101306748B1 (en) * 2012-03-29 2013-09-10 주식회사 바이오알파 Tunable hyaluronic acid-calcium phosphate complexes with delivery rate of growth factors and preparation method thereof
JP6394916B2 (en) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス Dry hemostatic composition
CA2883055C (en) 2012-09-13 2021-02-09 Avraham Amir Delivery devices and methods for skin augmentation
US10463762B2 (en) 2012-10-08 2019-11-05 Anteis S.A. Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
BR112015007772B1 (en) 2012-10-08 2020-05-05 Anteis Sa sterile injectable aqueous formulation containing cross-linked hyaluronic acid and hydroxyapatite for aesthetic use
US10434040B2 (en) 2012-10-08 2019-10-08 Anteis S.A. Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
US9272072B1 (en) 2012-10-19 2016-03-01 Nuvasive, Inc. Osteoinductive bone graft substitute
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
JP6861151B2 (en) * 2014-08-05 2021-04-21 ザ ユニバーシティ オブ メンフィス Compositions and Methods for Improving Bone and Soft Tissue Healing and Regeneration
JP6726852B2 (en) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス Dry composition for use in hemostasis and wound healing
JP6747650B2 (en) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding and mixing the first substance and the second substance
MX2017009241A (en) 2015-01-16 2018-03-23 Spineovations Inc Method of treating spinal disk.
US10195305B2 (en) 2015-03-24 2019-02-05 Orthovita, Inc. Bioactive flowable wash-out resistant bone graft material and method for production thereof
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
JP2019534130A (en) 2016-10-27 2019-11-28 ディーファイン，インコーポレイティド Articulated osteotome with cement delivery channel
US11116570B2 (en) 2016-11-28 2021-09-14 Dfine, Inc. Tumor ablation devices and related methods
WO2018107036A1 (en) 2016-12-09 2018-06-14 Dfine, Inc. Medical devices for treating hard tissues and related methods
WO2018129180A1 (en) 2017-01-06 2018-07-12 Dfine, Inc. Osteotome with a distal portion for simultaneous advancement and articulation
US20210128778A1 (en) 2017-03-09 2021-05-06 Baxter International Inc. Solvent deposition system and methods
ES2897211T3 (en) * 2017-12-14 2022-02-28 Geistlich Pharma Ag Use of a Dry Implant Composition for the Preparation of an Injectable Aqueous Implant Formulation
KR102233325B1 (en) 2017-12-14 2021-03-29 가이스틀리히 파마 아게 Bone substitutes
JP7395113B2 (en) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス Method of preparing a hemostatic composition
EP3876856A4 (en) 2018-11-08 2022-10-12 Dfine, Inc. Tumor ablation device and related systems and methods
JP2022537697A (en) 2019-06-14 2022-08-29 ガイストリッヒ ファーマ アーゲー Bone Substitute Collagen Matrix or Granular Blend
BR112021021682A2 (en) 2019-06-14 2022-03-15 Geistlich Pharma Ag Injectable aqueous implant formulation containing ascorbic acid
US11498880B2 (en) 2019-07-26 2022-11-15 Warsaw Orthopedic, Inc. Calcium phosphate granules and methods of making them
US11433159B2 (en) * 2019-07-26 2022-09-06 Warsaw Orthopedic, Inc. Hydratable and flowable implantable compositions and methods of making and using them

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325111A1 (en) * 1983-07-12 1985-01-24 Merck Patent Gmbh, 6100 Darmstadt IMPLANTATION MATERIALS
JPS6117409A (en) * 1984-07-02 1986-01-25 Meishin Toryo Kk Preparation of amorphous calcium phosphate and bio-compatible composition composed mainly thereof
US5001169A (en) * 1984-10-24 1991-03-19 Collagen Corporation Inductive collagen-based bone repair preparations
US4563350A (en) * 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US4992226A (en) * 1985-03-28 1991-02-12 Collagen Corporation Method of making molds with xenogeneic collagen/mineral preparations for bone repair
CA1260391A (en) * 1985-03-28 1989-09-26 Karl A. Piez Xenogeneic collagen/mineral preparations in bone repair
US4776890A (en) * 1985-12-18 1988-10-11 Collagen Corporation Preparation of collagen hydroxyapatite matrix for bone repair
CA1294876C (en) * 1986-04-22 1992-01-28 Karl A. Piez Marrow/collagen/mineral matrix for bone defect repair
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4743229A (en) * 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
US4865602A (en) * 1986-11-06 1989-09-12 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
ZA93506B (en) * 1992-02-11 1994-05-11 Bristol Myers Squibb Co Soft tissue augmentation material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389017B1 (en) 1999-07-08 2013-03-05 Cap Biotechnology, Inc. Calcium-containing structures and methods of making and using the same
US9969971B2 (en) 1999-07-08 2018-05-15 Cap Biotechnology, Inc. Calcium-containing structures and methods of making and using the same

Also Published As

Publication number Publication date
EP0627899A1 (en) 1994-12-14
EP1120439A1 (en) 2001-08-01
CA2128783C (en) 2004-10-12
WO1993016657A1 (en) 1993-09-02
US5352715A (en) 1994-10-04
AU3619693A (en) 1993-09-13
EP0627899A4 (en) 1996-11-13
DE69331096D1 (en) 2001-12-13
AU666712B2 (en) 1996-02-22
ATE208217T1 (en) 2001-11-15
EP0627899B1 (en) 2001-11-07
EP1120439B1 (en) 2004-06-16
DE69333556D1 (en) 2004-07-22
ATE269371T1 (en) 2004-07-15
DE69331096T2 (en) 2002-08-14
DE69333556T2 (en) 2005-06-30
ES2167330T3 (en) 2002-05-16
JPH07504106A (en) 1995-05-11

Similar Documents

Publication Publication Date Title
CA2128783A1 (en) Injectable ceramic compositions and methods for their preparation and use
JP3168007B2 (en) How to use biomaterials for tissue repair
Saito et al. Experimental studies on a new bioactive bone cement: hydroxyapatite composite resin
ATE307620T1 (en) IMPLANT MATERIAL WITH GLASS PARTICLES
WO2004045372A3 (en) Cohesive demineralized bone compositions
EP0444157A4 (en) Collagen-polymer conjugates
EP1752168A3 (en) Augmentation of organ function
CA2296374A1 (en) Semi-interpenetrating polymer networks
CA2201526A1 (en) Differentially biodegradable biomedical implants
DE69121675T2 (en) Pharmaceutical composition containing microsphere with controlled release and method of manufacture
CA2063819A1 (en) Chewing gum composition with accelerated, controlled release of active agents
AU6331898A (en) Forskohlin for promoting lean body mass
AU5609798A (en) Injectable depot gel composition and method of preparing the composition
DE59905880D1 (en) POROUS COMPOSITE MATRIX, THEIR PREPARATION AND USE
CA2369302A1 (en) Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
DE102005036637A1 (en) Curable acrylate-polymer composition with improved flexural properties
EP0820737A3 (en) Artificial dental implant
BR0214663A (en) Resorbable polymer composition, implant and implant production method
CA2280966A1 (en) Implantable collagen-containing putty material
Burres Preserved particulate fascia lata for injection: a new alternative
CA2106105A1 (en) Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
Girdler Repair of articular defects with autologous mandibular condylar cartilage
CA2027259A1 (en) Bone Collagen Matrix for Implants
CA2516728A1 (en) Biodegradable bone implant material
PH27266A (en) WS7622, A,B,C and D substances and pharmaceutical composition containing same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20130218